Rashid Hussain | Genetic Engineering | Best Innovation Award

Published on by New Scientists

Best Innovation Award

Rashid Hussain
Karakoram International University , Pakistan
Rashid Hussain
Affiliation Karakoram International University
Country Pakistan
Scopus ID 58102963300
Documents 9
Citations 68
h-index 4
Subject Area Genetic Engineering
Event New Scientists Awards
ORCID 0000-0003-3260-7280

Rashid Hussain recognizes the Best Innovation Award  who demonstrate notable contributions to scientific advancement through innovative research and scholarly activities. Rashid Hussain has contributed to the field of Genetic Engineering through research addressing contemporary challenges in biotechnology, molecular genetics, and applied life sciences. His academic output and citation record reflect active engagement with emerging scientific questions and interdisciplinary research initiatives.[1]

Abstract

Genetic Engineering continues to play a pivotal role in advancing biotechnology, agriculture, medicine, and environmental sustainability. Rashid Hussain’s research portfolio demonstrates engagement with molecular approaches aimed at understanding biological systems and developing innovative applications. His scholarly work contributes to the broader scientific effort to improve genetic technologies and their practical implementation.[2]

Keywords

Genetic Engineering, Biotechnology, Molecular Genetics, Genome Research, Gene Expression, Biological Innovation, Applied Biotechnology, Scientific Research.

Introduction

The rapid evolution of genetic technologies has transformed modern biological sciences. Researchers working within this domain contribute to advances in healthcare, agriculture, and environmental management. Rashid Hussain’s academic activities are aligned with these developments through investigations that support scientific understanding and practical applications of genetic engineering methodologies.[3]

Research Profile

Affiliated with Karakoram International University, Rashid Hussain has established a research profile focused on biotechnology and genetic engineering. His scholarly record includes peer-reviewed publications indexed in international databases. Through collaborative and interdisciplinary research, he has contributed to the dissemination of scientific knowledge within his field.[1]

Research Contributions

  • Research contributions in genetic engineering and biotechnology.
  • Participation in studies involving molecular and cellular biological systems.
  • Support for scientific innovation through experimental and analytical methodologies.
  • Contribution to academic literature and research dissemination.
  • Engagement with interdisciplinary scientific collaborations.

Publications

The researcher’s publication record includes articles addressing topics related to biotechnology, genetic engineering, and molecular research. These publications contribute to the scientific community’s understanding of biological processes and innovative genetic methodologies.[4]

Research Impact

With 68 citations and an h-index of 4, the available bibliometric indicators suggest measurable scholarly influence within the research community. Citation metrics provide evidence that published work has been referenced by other researchers, supporting knowledge exchange and scientific development.[1]

Award Suitability

The Best Innovation Award acknowledges individuals whose research demonstrates originality, scientific relevance, and commitment to advancing knowledge. Rashid Hussain’s work in Genetic Engineering aligns with these objectives through scholarly contributions, publication activity, and participation in contemporary scientific research initiatives.[5]

Conclusion

Rashid Hussain represents an emerging contributor within the field of Genetic Engineering. His research activities, publication record, and scholarly engagement support ongoing scientific progress and reflect the qualities recognized by innovation-focused academic awards.

References

  1. Elsevier. (n.d.). Scopus author details: Rashid Hussain, Author ID 58102963300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58102963300
  2. National Human Genome Research Institute. (n.d.). Genetic Engineering Overview.
    https://www.genome.gov/
  3. Nature Biotechnology. (2015). Advances in Genome Engineering.
    https://doi.org/10.1038/nbt.3121
  4. National Center for Biotechnology Information. (n.d.). Biotechnology and Molecular Research Resources.
    https://www.ncbi.nlm.nih.gov/
  5. New Scientists Awards. (n.d.). Award Recognition and Evaluation Framework.
    https://newscientists.net/

Xiaomei Lyu | Genetic Engineering and Biotechnology | Best Researcher Award

Published on by New Scientists

Prof. Xiaomei Lyu | Genetic Engineering and Biotechnology | Best Researcher Award

Professor | Jiangnan University | China

Prof. Xiaomei Lyu is a leading researcher in synthetic biology-driven food science, microbial engineering, and biotechnology. Her work focuses on designing programmable microbial systems, metabolic pathway engineering, and CRISPR-based genetic regulation for applications in food functionality, metabolic health, and biomanufacturing. Her research contributions span high-impact areas such as microbial biosensing, host–microbe interaction engineering, and sustainable biosynthesis of value-added compounds. Prof. Xiaomei Lyu has contributed significantly to the development of engineered microbial genetic circuits targeting biomedical and functional-food applications. Her notable advancements include CRISPR-regulated biosensing systems and controllable nanocarriers enabling active delivery of gene-editing components (Small, 2021). She has also pioneered strategies for modularizing and optimizing metabolic pathways in microbial chassis to enhance production efficiency of nutraceutical compounds, as demonstrated in her work on delta-tocotrienol biosynthesis (Journal of Agricultural and Food Chemistry, 2023). Her research on Rhizobium-derived beta-glucan has opened new avenues in microbiota-modulated metabolic regulation. These works revealed mechanisms by which microbial polysaccharides influence triglyceride metabolism, intestinal fat absorption, and gut–host crosstalk, producing valuable implications for obesity and metabolic disorder interventions (Food & Function, 2022; 2024). Additionally, Prof. Xiaomei Lyu has made recognized contributions to enzymatic and chemo-catalytic processes relevant to food biotechnology, including lactulose production and salidroside biosynthesis, helping advance industrial and functional food innovation. Her publication record includes influential papers in Nature Communications, Small, Food & Function, Biotechnology Advances, Phytochemical Reviews, and Journal of Agricultural and Food Chemistry, supported by strong citation performance (Scopus: 1,515 citations, 59 documents, h-index 22). Her scholarly impact extends to R&D in microbial engineering, biochemical pathways, food-derived therapeutics, and microbiome-based metabolic interventions. Prof. Xiaomei Lyu’s research achievements establish her as a prominent contributor to next-generation microbial biotechnology, functional food science, and precision metabolic modulation.

Profiles: Scopus | ResearchGate | Sci Profiles

Featured Publications

1. Gu, B., Zhang, W.-D., Feng, J.-D., Zhao, W., Gu, Z.-G., & Lyu, X. (2025). Upcycling CO₂ into single cell protein via an integrated electrocatalytic–biosynthetic system. ACS Sustainable Chemistry & Engineering. https://doi.org/10.1021/acssuschemeng.5c06506

2. Wang, L., Zeng, Q., Gu, J., Wang, M., Yang, R., & Lyu, X. (2025). High conversion of value-added lactulose from lactose-rich dairy waste by in vivo cascade cell factory. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c03933

3. Zeng, Q., & Lyu, X. (2025). Identification of a novel cellobiose 2-epimerase from Acidobacteriota bacterium and its application for in-situ milk catalysis. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1575725

4. Liu, H., Zeng, Q., Zhu, C., Xu, C., Yang, R., & Lyu, X. (2025). High-throughput screening and directed evolution of β-1,3-N-acetylglucosaminyltransferase for enhanced LNnT production in engineered Saccharomyces cerevisiae. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c01311

5. Liu, H., Liu, Y., Hu, H., Zhang, S., Lyu, X., & Yang, R. (2024). De novo production of LNnT by metabolic engineering of Saccharomyces cerevisiae as cell factory. Food Science and Human Wellness. https://doi.org/10.26599/fshw.2024.9250342

R Sagaya Jansi | Biotechnology | Best Researcher Award

Published on by New Scientists

DR. R Sagaya Jansi | Biotechnology | Best Researcher Award

Assistant Professor, Stella Maris College, India

Dr. R Sagaya Jansi is an Assistant Professor in the PG Department of Bioinformatics at Stella Maris College, India, where she has served as Head of the Department since November 2019 and currently coordinates the IQAC. She earned her Ph.D. in Biotechnology (Plant Biology and Plant Biotechnology) and an M.Phil. in Plant Biology and Plant Biotechnology from Loyola College, Chennai, India, along with an M.Sc. in Biotechnology from Loyola College and a B.Sc. in Advanced Zoology and Biotechnology from Stella Maris College. She has also cleared CSIR-NET (Life Sciences, 2018), SET (Life Sciences, 2012) and GATE (2011). Dr. Jansi’s research focuses primarily on plant biotechnology and the integration of bioinformatics in molecular modeling, computer-aided drug design, genomics, and proteomics, with emerging work bridging computational approaches and molecular biology to address challenges in biomedical and plant sciences. She has extensive teaching and research experience, having served as Assistant Professor at Loyola College, Research Assistant at the Bioinformatics Infrastructure Facility (DBT, Madras Christian College), and educator at Our Lady’s Matriculation Higher Secondary School, handling subjects including molecular biology, clinical research management, bioinformatics, programming in C++, and biophysics. Her key contributions include docking studies of bioflavonoids targeting anti-apoptotic pathways, development of bioinformatics infrastructure, and designing interdisciplinary educational programs that integrate biotechnology and computational biology. She has been recognized with the T. A. Venkateswaran Prize (II Rank, M.Sc.) and a Gold Medal (I Rank, M.Phil.), alongside multiple institutional awards for research and academic excellence. Dr. R Sagaya Jansi actively participates in academic societies, departmental leadership and IQAC coordination, mentoring students and contributing to curriculum development. Her work advances scientific understanding, fosters innovation, and supports global knowledge dissemination. Author metrics: 7 documents, 70 citations, h-index 4. With strong potential for international collaborations, Q1 publications, and research leadership, Dr. R Sagaya Jansi is highly deserving of recognition for advancing bioinformatics and biotechnology research excellence.

Profile: Scopus | ORCID | ResearchGate | Scispace | Stella Maris College | LinkedIn

Featured Publications

1. Sagaya Jansi, R., Khusro, A., Agastian, P., Kumar, G. A., Kadaikunnan, S., Khaled, J. M., & Thiruvengadam, M. (2024). Bioassay-guided fractionation and in vitro and in silico biological activities of 2,4-di-tert-butylphenol isolated from Nocardiopsis sp. strain LC-8. Chinese Journal of Analytical Chemistry.

2. Latha, R., Sarkar, T., Sagaya, J. R., & Agastian, P. (2015). Evaluation of antimicrobial efficiency and alpha-glucosidase inhibition of Rubus ellipticus Smith. leaf extracts and its phytochemical analysis. Asian Journal of Pharmaceutical and Clinical Research, 8(2), 422–426.

3. Latha, R., Saravana Kumar, P., Sagaya Jansi, R., Venkatadri, B., & Agastian, P. (2015). Antimicrobial efficacy and α-glucosidase inhibition of Passiflora mollissima Bailey leaves and its phytochemical analysis. International Journal of Pharmaceutical Research and BioScience, 4(4), 62–78.

4. Aparna, K., Sagaya Jansi, R., Arul Samraj, D., & Joyce PriyaKumari, C. (2013). Homology modelling and docking studies of phospholipase A2 enzyme of Apis mellifera. Journal of Current Pharmaceutical Research, 11(1), 33–37.

5. Joyce Priyakumari, C., Aparna, K., Sagaya Jansi, R., & Gladies Kezia. (2014). Phytochemical analysis of Didymocarpus pedicellatus. International Journal of Pharmaceutical Sciences Review and Research, 25(1), 307–309.

 

Zu-Chian Chiang | Biotechnology | Best Researcher Award

Published on by New Scientists

Dr. Zu-Chian Chiang | Biotechnology | Best Researcher Award

Zu-Chian Chiang at Fujian Normal University, China.

Dr. Zu-Chian Chiang is a materials scientist and biomedical researcher specializing in antibody–drug conjugates (ADCs), aptamer-based therapeutics, and functional biomaterials for cancer therapy and regenerative medicine. With a strong foundation in chemical engineering and molecular design, his research spans across Taiwan and China, advancing innovative strategies in translational medicine.

Publication Profile

Scopus

Educational Details

  • Ph.D. in Materials and Chemical Engineering
    National United University, Taiwan | Sept 2008 – Jul 2014

    • Advisor: Prof. An-Chong Chao

    • Co-Advisor: Dr. Guo-Chung Dong, NHRI

  • M.S. in Chemistry
    Tunghai University, Taiwan | Sept 2005 – Aug 2007

    • Advisor: Prof. Feng-Di Lung

Professional Experience

Dr. Chiang has extensive postdoctoral research experience in interdisciplinary biomedical research.

  • Postdoctoral Fellow
    Fujian Normal University, Biomedical Research Center of Southern China (2019–Present)
    Focus: Development of ADCs and aptamers in cancer therapy under Prof. Qi Chen.

  • Postdoctoral Fellow
    Academia Sinica, Institute of Biological Chemistry (2016–2019)
    Participated in the Taiwan Protein Project (TPP) and the TSPA platform, supervised by Academician Hui-Kung Wang.

  • Postdoctoral Fellow
    Clinical Trial Center, National Taiwan University Hospital (2015–2016)
    Selected for the 3rd Biotech Elite Training Reserve Program (MOST). Mentored by Dr. Chih-Hao Chang.

Teaching Experience

  • Served as a Teaching Assistant (2005–2013) in a wide range of chemistry and chemical engineering subjects including Organic Chemistry, Physical Chemistry, Thermodynamics, and Instrumental Analysis at both Tunghai University and National United University.

Research Interest

  • Design and synthesis of functional peptides for cancer therapy and bone tissue regeneration

  • Development of biomicro- and macromolecular composites for regenerative medicine

  • Engineering antibody–drug conjugates (ADCs) for targeted cancer treatment

  • Construction of aptamers as molecular blockers, agonists, or antagonists in oncology applications

Author Metrics

  • Total Publications: 7 peer-reviewed journal articles

  • Total Citations: 93 (as of latest data)

  • h-index: 5

  • Research Interest Score: 49.5 (ResearchGate metric)

Top Noted Publication

Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo

Authors:
Z.C. Chiang (Zu-Chian Chiang), S. Fang (Shubin Fang), Y. Shen (Yangkun Shen), D. Cui, H. Weng, D. Wang, Y. Zhao, J. Lin (Jizhen Lin), Q. Chen (Qi Chen)

Journal:
Frontiers in Oncology
Year: 2022
Volume: 12
Article ID: 857927
DOI: 10.3389/fonc.2022.857927
Access: Article • Open Access
Article Type: Original Research

Author Roles:

  • First Author: Zu-Chian Chiang

  • Co-first Author: Shubin Fang (#)

  • Corresponding Authors: Jizhen Lin*, Qi Chen*

Summary:
This study presents the design and evaluation of novel CD47-targeting antibody–drug conjugates (ADCs) with high antitumor efficacy against non-small cell lung cancer (NSCLC), demonstrating promising therapeutic potential both in vitro and in vivo.

Conclusion

Dr. Zu-Chian Chiang is an emerging talent in the biotechnology research community, with a clear trajectory toward impactful innovation in cancer therapy and regenerative medicine. His demonstrated strengths in antibody–drug conjugates, biomaterials design, and molecular therapeutics showcase both technical expertise and translational vision.

 

Mozhgan Abasi | Biotechnology | Best Researcher Award

Published on by New Scientists

Assist. Prof. Dr. Mozhgan Abasi | Biotechnology | Best Researcher Award

Mozhgan Abasi at Mazandaran University of Medical Sciences, Iran.

Assist. Prof. Dr. Mozhgan Abasi is a Medical Biotechnology researcher with expertise in stem cell therapy, tissue engineering, genetic engineering, and bioinformatics. She earned her Ph.D. in Medical Biotechnology from Tabriz University of Medical Sciences, Iran, where she focused on lentiviral vector-mediated gene expression in apoptosis pathways. With a strong background in molecular and cellular biology, she has conducted extensive research in induced pluripotent stem cells (iPSCs), cancer stem cells, and non-coding RNA. Dr. Abasi is a member of multiple scientific societies, including the Iran Biotechnology Society and the iPS Biotechnology Team. Her work integrates molecular techniques, bioinformatics, and microbiological approaches to advance regenerative medicine and genetic research.

Publication Profile

Scopus

Orcid

Google Scholar

Educational Details

  • Ph.D. in Medical Biotechnology (2011-2017) – Tabriz University of Medical Sciences, Tabriz, Iran
    Thesis: Study on the effect of lentiviral vector-mediated 7SK snRNA overexpression on mRNA levels of apoptosis-related markers BCL2 and BAX in HEK293T cells.
  • M.Sc. in Molecular and Cellular Biology (2009-2011) – National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    Thesis: The study of dopaminergic differentiation of Nurr1 and GPX1 co-expressing ES cells induced by BBA.
  • B.Sc. in Biotechnology (2004-2008) – Department of Biology, Faculty of Science, Al Zahra University, Tehran, Iran.

Professional Experience

Dr. Mozhgan Abasi is an Assistant Professor specializing in Medical Biotechnology. She has extensive expertise in stem cell research, genetic engineering, bioinformatics, and cancer biology. Her research focuses on iPS (induced pluripotent stem) cell generation, stem cell differentiation, tissue engineering, and nanoporous biomaterials. With a strong foundation in molecular and cellular biology, she has contributed significantly to understanding stem cell therapy and regenerative medicine.

Dr. Abasi has been an active member of multiple professional societies, including the Iran Bioinformatics Society (IBS), Iran Genetic Society (IGS), Iran Biotechnology Society, and the iPS Biotechnology Team (IBT). She has extensive experience in molecular techniques such as gene expression analysis, cloning, viral and non-viral gene transfer, and protein analysis methods like Western blotting and immunocytochemistry. Additionally, she is proficient in a range of bioinformatics tools used for primer design, shRNA analysis, gene expression studies, and molecular dynamics simulations.

Research Interest

  • Stem Cell Therapy
  • Tissue Engineering
  • Induced Pluripotent Stem Cells (iPSCs)
  • Cancer Stem Cells
  • Immune System Research
  • Microarray Analysis
  • Nanoporous Biomaterials
  • Bioinformatics & Non-Coding RNA
  • Genetic Engineering

Author Metrics

  • Total Citations: 1,821+

  • h-index: 17

  • i10-index: 6+

Top Noted Publication

  • Carbon nanotubes: properties, synthesis, purification, and medical applications

    • Citations: 1,462

    • Journal: Nanoscale Research Letters

    • Year: 2014

  • The effect of topography on differentiation fates of matrigel-coated mouse embryonic stem cells cultured on PLGA nanofibrous scaffolds

    • Citations: 101

    • Journal: Tissue Engineering Part A

    • Year: 2012

  • Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer

    • Citations: 94

    • Journal: Journal of Microencapsulation

    • Year: 2014

  • Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection

    • Citations: 91

    • Journal: Materials Science and Engineering: C

    • Year: 2019

  • Anti-tumoral properties of Punica granatum (Pomegranate) peel extract on different human cancer cells

    • Citations: 73

    • Journal: Asian Pacific Journal of Cancer Prevention

    • Year: 2015

  • Anti-proliferative properties of Cornus mass fruit in different human cancer cells

    • Citations: Over 50

    • Journal: Asian Pacific Journal of Cancer Prevention

    • Year: Not specified

Conclusion

Assist. Prof. Dr. Mozhgan Abasi is an exceptional researcher with significant contributions to biotechnology, genetic engineering, and regenerative medicine. Her high citation impact, strong expertise in molecular biology, and interdisciplinary research focus make her a strong contender for the Best Researcher Award.

While her achievements are commendable, further expanding international collaborations, increasing high-impact publications, and securing major research grants would solidify her position as a leading global researcher. Overall, Dr. Abasi is highly deserving of recognition for her contributions to the scientific community and biotechnology advancements.